tiprankstipranks
Trending News
More News >
Omega Diagnostics Group PLC (GB:CNSL)
LSE:CNSL
UK Market

Omega Diagnostics (CNSL) Income Statement

Compare
3 Followers

Omega Diagnostics Income Statement

Last quarter (Q2 2025), Omega Diagnostics's total revenue was £3.86M, a decrease of -21.71% from the same quarter last year. In Q2, Omega Diagnostics's net income was £-397.00K. See Omega Diagnostics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
£ 8.33M£ 9.77M£ 7.55M£ 8.54M£ 6.82M
Gross Profit
£ 5.00M£ 6.05M£ 3.17M£ 4.75M£ 4.00M
Operating Expenses
£ 5.64M£ 6.58M£ 5.95M£ 5.33M£ 4.28M
Depreciation and Amortization
£ 615.00K£ 650.00K£ 591.00K£ 547.00K£ 886.00K
EBITDA
£ 2.20M£ -73.00K£ -2.65M£ -382.00K£ 418.00K
Operating Income
£ -640.00K£ -535.00K£ -2.78M£ -582.00K£ -488.00K
Other Income/Expenses
£ 2.21M£ -210.00K£ -473.00K£ -358.00K£ -78.00K
Pretax Income
£ 1.57M£ -745.00K£ -3.25M£ -950.00K£ -546.00K
Net Income
£ 1.57M£ -328.00K£ -3.86M£ -11.33M£ -2.10M
Per Share Metrics
Basic EPS
£ 0.01£ 0.00£ -0.02£ -0.06£ -0.01
Diluted EPS
£ 0.01£ 0.00£ -0.02£ -0.06£ -0.01
Weighted Average Shares Outstanding
238.27M 237.73M 231.26M 182.64M 171.69M
Weighted Average Shares Outstanding (Diluted)
238.27M 238.10M 231.26M 182.64M 177.10M
Currency in GBP

Omega Diagnostics Earnings and Revenue History